1887
Rapid communications Open Access
Like 0

Abstract

During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus. One-dose vaccination was recommended for all age groups. We applied the screening method for the rapid assessment of vaccine effectiveness (VE) based on reported data of vaccinated and unvaccinated pandemic influenza cases and vaccination coverage estimates. Preliminary results demonstrate excellent VE in persons aged 14-59 years (96.8%; 95% confidence interval (CI): 95.2-97.9) and moderately high VE in those 60 years or older (83.3%; 95% CI: 71.0-90.5).

Loading

Article metrics loading...

/content/10.2807/ese.15.18.19561-en
2010-05-06
2017-12-12
http://instance.metastore.ingenta.com/content/10.2807/ese.15.18.19561-en
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/15/18/art19561-en.htm?itemId=/content/10.2807/ese.15.18.19561-en&mimeType=html&fmt=ahah
Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error